Holen Sie sich die Stockscreener-App
9.32
3.62%
-0.35
Handel nachbörslich:
9.26
-0.06
-0.64%
Schlusskurs vom Vortag:
$9.67
Offen:
$9.66
24-Stunden-Volumen:
997.20K
Relative Volume:
0.92
Marktkapitalisierung:
$743.30M
Einnahmen:
$116.30M
Nettoeinkommen (Verlust:
$17.73M
KGV:
44.38
EPS:
0.21
Netto-Cashflow:
$20.88M
1W Leistung:
-5.09%
1M Leistung:
-3.32%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.1869
$9.79
1-Wochen-Bereich:
$9.1869
$10.06
52-Wochen-Spanne:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Firmenname
Niagen Bioscience Inc
Sektor
Branche
Telefon
310-388-6706
Adresse
10900 WILSHIRE BLVD, LOS ANGELES
Vergleichen Sie NAGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.32 | 787.96M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-08-16 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-02-14 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-01-03 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Will Niagen Bioscience Inc. outperform the market2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Niagen Bioscience (NASDAQ:NAGE) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Is Niagen Bioscience Inc. stock bottoming out2025 Historical Comparison & Daily Entry Point Trade Alerts - Newser
Can swing trading help recover from Niagen Bioscience Inc. lossesJuly 2025 Update & AI Driven Stock Reports - Newser
Will Niagen Bioscience Inc. bounce back from current supportFed Meeting & Weekly High Potential Stock Alerts - Newser
How sensitive is Niagen Bioscience Inc. to inflationJuly 2025 Price Swings & Precise Buy Zone Identification - khodrobank.com
Can Niagen Bioscience Inc. deliver consistent EPS growthJuly 2025 Levels & Real-Time Price Movement Reports - khodrobank.com
Multi factor analysis applied to Niagen Bioscience Inc.Earnings Summary Report & High Yield Equity Trading Tips - Newser
Is it too late to sell Niagen Bioscience Inc.2025 Volatility Report & Verified Entry Point Signals - Newser
What momentum shifts mean for Niagen Bioscience Inc.2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
Published on: 2025-09-03 22:51:56 - Newser
Is Niagen Bioscience Inc. showing insider buyingQuarterly Risk Review & Entry Point Strategy Guides - khodrobank.com
Real time scanner hits for Niagen Bioscience Inc. explainedRate Hike & Weekly High Conviction Ideas - Newser
Chart based exit strategy for Niagen Bioscience Inc.Gap Down & Long-Term Investment Growth Plans - Newser
Is Niagen Bioscience Inc. stock poised for growthCEO Change & Precise Entry and Exit Recommendations - Newser
Applying big data sentiment scoring on Niagen Bioscience Inc.Oil Prices & Target Return Focused Stock Picks - Newser
Is a relief rally coming for Niagen Bioscience Inc. holdersMarket Performance Recap & Real-Time Sentiment Analysis - Newser
Real time alert setup for Niagen Bioscience Inc. performanceLayoff News & Safe Entry Point Alerts - Newser
How to use Fibonacci retracement on Niagen Bioscience Inc.2025 Major Catalysts & Capital Efficiency Focused Strategies - Newser
Analysts Set Niagen Bioscience, Inc. (NASDAQ:NAGE) Target Price at $13.42 - MarketBeat
Published on: 2025-09-03 01:58:14 - Newser
Does Niagen Bioscience Inc. show high probability of reboundGold Moves & Smart Swing Trading Techniques - Newser
Is Niagen Bioscience Inc. stock reversal real or fake2025 Price Targets & Technical Pattern Based Buy Signals - Newser
Using economic indicators to assess Niagen Bioscience Inc. potentialJuly 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Niagen Bioscience Inc. stock chart pattern explainedEarnings Beat & AI Enhanced Execution Alerts - Newser
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Intrinsic Value Is Potentially 91% Above Its Share Price - Yahoo Finance
Published on: 2025-09-02 10:16:45 - Newser
Historical volatility pattern of Niagen Bioscience Inc. visualizedWeekly Market Report & Daily Chart Pattern Signal Reports - Newser
Niagen Bioscience Inc. stock momentum explainedQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Should you hold or exit Niagen Bioscience Inc. nowJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
Key metrics from Niagen Bioscience Inc.’s quarterly dataMarket Risk Summary & Technical Pattern Based Signals - Newser
Is Niagen Bioscience Inc. forming a reversal pattern2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Real time pattern detection on Niagen Bioscience Inc. stockInsider Selling & Stepwise Trade Execution Plans - Newser
How to track smart money flows in Niagen Bioscience Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - Newser
What’s the recovery path for long term holders of Niagen Bioscience Inc.2025 Macro Impact & AI Enhanced Trading Alerts - Newser
Finanzdaten der Niagen Bioscience Inc-Aktie (NAGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Niagen Bioscience Inc-Aktie (NAGE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel |
Mar 07 '25 |
Buy |
7.86 |
273 |
2,146 |
2,251 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):